Radiotherapy, the backbone of the standard of care for gliomas, has the unintended effect of promoting tumor recurrence via CXCR4/CXCR7-dependent vasculogenesis (discussed under ‘Angiogenesis and vasculogenesis inhibitors’). Here, CXCR4 is linked to neoplasm.